WADA – World Anti-Doping Agency
The World Anti-Doping Agency (WADA) launches a stakeholder consultation process to refine and revise the Technical Document for Blood Analytical Requirements for the Athlete Biological Passport (ABP) (TD2019BAR). This Technical Document harmonizes the analysis of blood samples collected for the measurement of individual athlete blood markers within the framework of the ABP.
Stakeholders are invited to review the TD2019BAR and provide comments by 1 April 2019, using WADA’s online consultation platform, WADAConnect.
Once the consultation process is completed, stakeholders will be advised that the new TD2019BAR is to replace the TD2018BAR that is currently in force.
WADA’s Technical Documents provide specific technical recommendations to Anti-Doping Organizations and WADA-accredited laboratories. The Documents are refined and revised in consultation with WADA stakeholders.
For any questions related to the above, we invite you to contact firstname.lastname@example.org.
We thank you in advance for your feedback.
World Anti-Doping Agency
In 2016, the World Anti-Doping Agency (WADA) initiated development of its ISO9001:2015 certified Compliance Monitoring Program; and since 2017, WADA has been monitoring Signatories’ compliance with the World Anti-Doping Code (Code) mainly through the Code Compliance Questionnaire (CCQ) and the Signatory Audit program.
So far, WADA has issued Corrective Action Reports (CARs) to all 307 Signatories that received and completed the CCQ; and, work is ongoing with a number of Signatories. In addition, WADA has conducted around 30 audits on both International Federations (IFs) and National Anti-Doping Organizations (NADOs), with a total of 19 audits planned for 2019.
We wish to thank all Signatories for the energy and efforts that have been put into the implementation of the corrective actions, which contribute significantly to protecting the integrity of sport worldwide.
Given that the next CCQ will not be issued until early 2022 to assess the implementation of the revised Code and International Standards, which will come into effect on 1 January 2021; in early 2019, WADA launched an enhanced “Continuous Monitoring Program” for Code Signatories, which we wish to detail for you today. In short, the Continuous Monitoring Program includes the following elements:
Monitoring the entry of Doping Control Forms (DCFs) into the Anti-Doping Administration & Management System (ADAMS). Since the introduction of this initiative, DCF entry has increased globally from 60% in 2015 to 98% today. Nonetheless, as a reminder, it is critical that Signatories enter DCFs into ADAMS within 15 business days of sample collection to enable a meaningful steroidal and haematological Athlete Biological Passport (ABP) program to operate worldwide; to facilitate coordinated test distribution planning; and, to avoid unnecessary duplication in testing by Anti-Doping Organizations (ADOs);
Monitoring Therapeutic Use Exemption (TUE) applications and decisions, both in terms of timely input into ADAMS (TUE decisions within 15 business days after the TUE Committee makes its decision) and the quality of submissions provided;
Monitoring Results Management cases to ensure that due process is followed and cases are closed in a timely fashion;
Conducting remote, post-audit review of Signatories previously audited, to ensure that compliance is maintained and does not revert back following a WADA audit;
Issuing Mandatory Information Requests (MIRs) under Article 8.6 of the International Standard for Code Compliance by Signatories (ISCCS), if needed, to ensure compliance of activities associated with Critical or High Priority requirements; and
Monitoring ABP programs.
The purpose of the Continuous Monitoring Program is to bridge the gap between the CCQ issued in 2017 and the next release planned in early 2022, to ensure compliance of anti-doping programs worldwide and to maintain athlete confidence in the global anti-doping system.
In addition to these activities, WADA is also implementing a compliance monitoring program tailored towards the activities of Major Event Organizations (MEOs). This program will be introduced to the International Olympic Committee (IOC) and International Paralympic Committee (IPC) in advance of the Tokyo 2020 Summer Olympic and Paralympic Games.
Requests and reminders to Signatories
As WADA rolls out the full Compliance Monitoring Program, Signatories may receive requests and reminders from different WADA departments and will continue to receive support from WADA, including from the Regional Offices. WADA will aim to ensure that the messaging is coordinated as much as possible; however, we thank Signatories in advance for responding to the relevant departments within the deadlines provided. While we conduct this program in a cooperative spirit, we wish to remind you that under the ISCCS, if deadlines are missed, the Signatory may be reported to WADA’s internal Compliance Taskforce, which may result in it being asserted non-compliant by the Executive Committee following a recommendation from the external, independent Compliance Review Committee.
Upcoming ADAMS enhancements to assist Signatories
To support Signatories with their compliance responsibilities, a number of new functions will be released in ADAMS as the ADAMS Next Gen project progresses. In particular, a new Test Distribution Plan (TDP) and Technical Document for Sport Specific Analysis (TDSSA) monitoring tool will be introduced in the coming weeks, which will enhance the efficiency of Signatories monitoring their TDP and TDSSA compliance in real-time.
Update on WADA’s Compliance Monitoring Program
In addition to the excellent response from Signatories to increasing DCF entry in ADAMS from 60% in 2015 to 98% today, the following are some of the numerous collective achievements WADA wishes to share with Signatories:
Over 3,700 corrective actions have been implemented by Signatories to date following receipt of their CCQ Corrective Action Report (CAR).
Over 540 corrective actions have been implemented by Signatories to date following receipt of their audit CAR.
Several countries have introduced new legislation or amended their existing legislation to enhance their anti-doping programs through the Compliance Monitoring Program.
Under WADA’s enhanced Compliance Monitoring Program, only five Signatories have been declared non-compliant and three of these have been reinstated, thanks mainly to enhanced cooperation and coordination with WADA and other stakeholders.
Several Signatories have entered into partnerships with other Signatories to enhance their anti-doping programs.
WADA would like to thank all Signatories for the significant collective effort to date and looks forward to working with all involved in the continued development of the global anti-doping program.
Please feel free to contact us with any questions or concerns that you may have at email@example.com.
World Anti-Doping Agency
ATHLETE SESSION BRINGS TOGETHER MORE THAN 70 ATHLETES AND ATHLETE REPRESENTATIVES TO DISCUSS
CURRENT ISSUES AND PRIORITIES
Lausanne, 14 March 2019 – A crucial review of the World Anti-Doping Code (Code) and its associated International Standards, as well as compliance and capturing athletes’ views were among the main themes at the World Anti-Doping Agency’s (WADA’s) 15th Annual Symposium held this week in Lausanne, Switzerland.
The WADA Symposium, which is the leading fixture on the anti-doping calendar, gathered close to 900 delegates from the global anti-doping community for two days of presentations, interviews, panel discussions, practical workshops and networking sessions. Athlete representatives, International Sports Federations, government representatives, National and Regional Anti-Doping Organizations, Major Event Organizers, WADA-accredited laboratories and Athlete Passport Management Units, as well as international media and other stakeholders, gathered on 13 and 14 March under the theme “Towards 2021 – Navigating the Future Together”.
2021 will be the year when the latest revised and updated Code comes into effect and the world’s anti-doping stakeholders are currently finalizing the document in time for its ratification at the fifth World Conference on Doping in Sport, which will take place in November in Katowice, Poland. In addition, the Code’s various International Standards, including those related to results management, education, compliance, testing and investigations, therapeutic use exemptions, laboratories and privacy protection were discussed at length during the Symposium.
Athletes were well represented during the conference. In particular, around 75 athlete leaders gathered from around the world for a one-and-a-half-day session for them and their representatives. The session, which was hosted by WADA’s Athlete Committee, for the first time as part of the Agency’s Annual Symposium, reinforced the importance of athletes’ involvement in clean sport. Specifically, the session addressed topics such as increased athlete representation within WADA’s governance structure, the impact the proposed changes in the 2021 draft Code may have on athletes, and the upcoming launch of ADAMS Next Gen – the latest revamped and improved version of the system.
A Symposium highlight came as WADA’s Athlete Committee members Beckie Scott (Chair) and Ben Sandford gave an update in plenary session on the progress of the development of the Anti-Doping Charter of Athlete Rights, a topic that was also discussed at length during the athlete session.
The keynote address by WADA President Sir Craig Reedie on day one, entitled ‘Unity Will Be Our Strength’, set the tone for the Symposium as he reflected on the Russian doping scandal and on the progress made since the Executive Committee (ExCo) decision in September 2018 to reinstate the Russian Anti-Doping Agency (RUSADA) as compliant with the Code.
Sir Craig noted that the all-important data recovered from the Moscow Laboratory in January this year, once authenticated, would be used to bring more cheats to justice for the good of clean sport while exonerating others. He also pointed out that the Russian scandal had prompted the establishment of new priorities and led to significant changes that had already equipped the Agency to better navigate situations of non-compliance with the Code, including the coming into force on 1 April 2018 of the International Standard for Code Compliance by Signatories (ISCCS), which has considerably strengthened WADA’s legal framework around cases of non-compliance.
Sir Craig said: “In light of events that have occurred since the ExCo decision on RUSADA was made last September, it has been proven to be the right course of action. It is inarguable that accessing the laboratory data was a major step forward in this saga. Now we need to make sure this 24 terabytes of data is both complete and authentic.
“In case anyone had any doubts about the usefulness of the data from the Moscow Laboratory, some recent decisions from the Court of Arbitration for Sport put that into sharp focus and reinforced the importance of ensuring that due process is followed and that evidence is carefully presented.
“We are resolutely moving forward in our determination to protect clean sport. To continue to make impactful progress on all fronts, we need to work in partnership with everyone involved in anti-doping, whether that is athletes, National and Regional Anti-Doping Organizations, sports federations, governments, scientists, medical experts, educators and others. Division helps nobody except those trying to cheat. Unity will be our strength.”
Sir Craig went on to highlight enhanced intelligence and investigations activity as well as the ongoing success of WADA’s Speak Up! whistleblower program. He then flagged that WADA’s increased activities in these areas are being helped by the May 2018 decision of the Foundation Board to approve 8% budget increases for 2019-22.
WADA Director General, Olivier Niggli, took delegates through WADA’s strategic priorities, which in addition to those outlined by Sir Craig, included in particular: harmonizing Code rules via the 2021 Code Review and simultaneous review of the International Standards; the implementation of wide-ranging governance reforms, increasing scientific and social science research; enhancing education, most notably through the development of an International Standard for Education; capacity building of Anti-Doping Organizations; and the ongoing overhaul of WADA’s Anti-Doping Administration and Management System (ADAMS).
Niggli said: “The 2019 WADA Symposium has been a great opportunity for everyone in the anti-doping world to come together in a spirit of cooperation, to be brought up to date on the latest events and to influence the direction in which we are going.
“As the global regulator, this year’s Symposium has been very important for WADA as we put the finishing touches to the revised 2021 Code and associated International Standards that will be ratified at the World Conference on Doping in Sport later this year.”
Another highlight of the Symposium came on day one with a panel discussion entitled ‘Looking Back and Moving Forward Together’, which focused on improving the anti-doping system in light of the Russian crisis. Moderated by the CEO of British Rowing, Andy Parkinson, it featured representatives from the Caribbean Regional Anti-Doping Agency, the Government of Seychelles, UK Anti-Doping, the International Testing Agency, the United States Anti-Doping Agency and the Intelligence and Investigations Department of WADA.
With a backdrop of how the Russia situation affected the work of various anti-doping stakeholders, the lessons learned and the progress made since it came to light, the panel members discussed such issues as governance and funding of anti-doping bodies as well as the importance – and some of the goals and challenges – of scientific research, education, capacity building, compliance monitoring and investigations for the future integrity of sport.
Lastly, during the Symposium, participants heard a presentation on the consequences framework for the UNESCO Convention against Doping in Sport – currently in development – from Bram van Houten, Policy Adviser at the Netherlands Ministry of Health, Welfare and Sports, and a subsequent panel session that included Per Nylykke from the Danish Ministry of Culture, and Khalid Galant, CEO of the South African Institute for Drug-Free Sport.
Montreal, 21 February 2019
The World Anti-Doping Agency (WADA) announces that, following a circular vote of its Executive Committee (ExCo), the Agency has today removed the Nigerian National Anti-Doping Committee from the list of Signatories deemed non-compliant with the World Anti-Doping Code.
The Nigerian National Anti-Doping Committee was asserted non-compliant by WADA’s ExCo at its meeting of 14 November 2018 and this non-compliance became effective on 6 December 2018 after the Nigerian National Anti-Doping Committee chose not to challenge the assertion of non-compliance. Since then, the Nigerian National Anti-Doping Committee has implemented the corrective measures required to address its non-compliance, in cooperation with the South African Institute for Drug-Free Sport (SAIDS).
The Nigerian National Anti-Doping Committee continues to work with SAIDS and WADA to further enhance its program.
World Anti-Doping Agency
Montreal, 21 February 2019
Further to our communication of 10 December 2018 regarding the above-referenced, the World Anti-Doping Agency (WADA) wishes to remind you that 4 March 2019 is the deadline to submit feedback for:
I. The third phase of the 2021 World Anti-Doping Code (Code) Review Process
II. The second phase of the International Standards (Standards) Review Process
III. The first phase of the Anti-Doping Charter of Athlete Rights (Charter)
The whole review process culminates with approval at WADA’s next World Conference on Doping in Sport, which is to be held in Katowice, Poland in November 2019; after which, the revised 2021 Code and Standards will take effect on 1 January 2021.
I. CODE REVIEW: THIRD REVIEW PHASE
The third review phase is of the second draft revised version of the Code that resulted from comments received from stakeholders during the second review phase. Accordingly, we attach:
- The Clean version of the Code (following the second review phase)
- Two Redline versions of the Code (Second draft v First draft and Second draft v Current Code)
- The Comments received from stakeholders during the second review phase
- The Summary of major proposed changes
II. INTERNATIONAL STANDARDS: SECOND REVIEW PHASE
In order to facilitate the review process, every Standard is listed below along with, where applicable, a Clean version, a Redline version, a Summary of major proposed changes and Comments received from stakeholders, all of which stem from the first round of consultation.
1. The International Standard for Therapeutic Use Exemptions (ISTUE) is undergoing its first major review since 2015 – although there were minor updates in 2016 and 2018.
Following examination of stakeholder feedback, a revised version of the document was drafted and presented to WADA’s Executive Committee (ExCo) in September 2018.
2. The International Standard for Code Compliance by Signatories (ISCCS), which took effect on 1 April 2018.
3. The International Standard for Education (ISE), which is a new Standard that WADA’s Foundation Board (Board) approved for development in November 2017. A first draft was published for public consultation in June 2018 after it was presented to WADA’s ExCo and Board in May 2018. Following consideration of the public comments and input received through the Global Education Conference held in October 2018, a second draft is now ready for stakeholder feedback.
4. The International Standard for Results Management (ISRM), which is a new Standard. The first draft was presented to WADA’s ExCo and Board in November 2018 and is now being circulated for stakeholder consultation. This Standard will undergo a second consultation phase following the May 2019 ExCo and Board meetings.
5. The International Standard for the Protection of Privacy and Personal Information (ISPPPI), which is the new version adopted by WADA’s ExCo in May 2018 to ensure alignment with the main principles of the European Union’s General Data Protection Regulation that came into force on 25 May 2018.
6. The International Standard for Testing and Investigations (ISTI), which will undergo two full rounds of consultation. The ISTI was distributed for the first round of consultation with marked up text to two sections for reasons outlined below:
- Due to issues faced with sample collection equipment last year (2018), WADA appointed a small working group to enhance the criteria for equipment in the ISTI. Additional criteria have been included within Article 6.3.4 of a draft revised ISTI.
- Over the past few years, WADA has received input from stakeholders, particularly Athlete Biological Passport (ABP) experts and Athlete Passport Management Units (APMUs), which proposed changes to Annex L of the ISTI.
Following the first round of consultation on the ISTI, and consideration of all comments from stakeholders regarding changes to the above two sections of the Standard, WADA’s ExCo approved all proposed changes at their meeting in November 2018; and, the revised ISTI will come into effect on 1 March 2019.
7. The International Standard for Laboratories (ISL), which is a particular situation. It should be noted that a revised version (v.10.0) of the ISL was already circulated to WADA-accredited laboratories for comment from 2 March to 30 April 2018; and, a second version was circulated to all stakeholders from 14 July to 14 September 2018. This particular review of the ISL was triggered by some urgent changes that could not reasonably wait until 2021. However, the ISL v.10.0 was not approved by the WADA ExCo as presented at its meeting in November 2018. The ExCo requested that the ISL v.10.0 be subject to a further round of stakeholder consultation before it could be considered for approval in May 2019. If approved, it is foreseen that the ISL v.10.0 will come into force in late 2019. The ISL may then undergo further revision in 2020 to bring it in line with the 2021 Code.
8. The International Standard for the Prohibited List is not part of the review process as it is reviewed annually via a separate stakeholder consultation.
As is the case for the Code Review, each Standard has dedicated drafting teams comprised of senior WADA staff and external experts that act as the review secretariat.
[Note: At this point, the Code and Standard documents are available in English only.]
III. ANTI-DOPING CHARTER OF ATHLETE RIGHTS: FIRST AND ONLY REVIEW PHASE
The goal of the Charter, which has been developed by WADA’s Athlete Committee, is to clearly outline athlete rights with respect to the fight against doping in sport. While athletes’ responsibilities towards clean sport are set out in the Code, the Charter aims to further support athletes worldwide in their right to compete in clean, ethical and fair sport.
The Charter is a standalone document. This latest draft includes a section containing 'actual' rights and a section containing 'aspirational' rights, with the 'actual rights' being referenced to the relevant sections of the Code or the International Standards.
The idea of developing the Charter was first tested by WADA’s Athlete Committee at WADA’s Annual Symposium in March 2017. After being well received by Symposium participants, the Committee followed up by conducting a global athlete survey as to its desired content. Since then, the Charter has been presented for discussion and feedback at various WADA events in 2018; including, the 2018 Annual Symposium in March; the first Global Athlete Forum in June; the ExCo and Board meetings in November; and, the various meetings of the Code Drafting Team.
TO SUBMIT FEEDBACK
As indicated above, we would ask you to propose recommendations no later than 4 March 2019 via WADAConnect, the Agency’s online consultation platform. Easy to use, WADAConnect will prompt you to create a user account and input your comments regarding aspects of the Code and/or Standards and/or Charter that are of particular interest to you. For more information related to WADAConnect, please refer to the simple user guide.
Stakeholders are asked, to the extent possible, to draw on practical experiences and propose recommendations that would benefit the fight for clean sport worldwide. In addition, stakeholders are asked to be as specific and clear as possible when making submissions, i.e. by proposing text to replace the existing text.
Please note that, in the interest of transparency, WADA will publish all comments on its website at the end of each phase of the consultation process; and that, unless otherwise notified, stakeholder credentials (i.e. username, organization and organization type) will be posted along with the comments.
We look forward to receiving your feedback. The high quality of stakeholder feedback that was collected during the 2009 and 2015 Code Review Processes was instrumental to ensuring that the Code be strengthened over time in protection of clean sport.
World Anti-Doping Agency
Montreal, 20 February 2019
Further to our communications of 29 November, 19 December and 4 February, the World Anti-Doping Agency (WADA) wishes to remind you that the deadline to register for the 15th edition of its Annual Symposium, which will be held on Wednesday, 13 March, and Thursday, 14 March 2019, at the SwissTech Convention Center in Lausanne, Switzerland, is 26 February.
Under the theme “Towards 2021 – Navigating the future together”, this year's Symposium will focus on the 2021 World Anti-Doping Code (Code) and International Standards review as we head towards November’s World Conference in Katowice, Poland. The event will also address the Anti-Doping Charter of Athlete Rights that is being developed by WADA’s Athlete Committee with the aim of including key principles within the 2021 Code.
Should you wish to register for the Symposium, please do so on the Symposium website by 26 February 2019. The website contains all relevant information regarding the event, including the detailed agenda and how to register.
Once registered, approved participants will receive a notification inviting them to download the delegate app. Via smartphone or tablet, the app will allow participants to access:
A personalized agenda with the session timings, locations and descriptions
A full list of participants
A floor plan and more event information
Also, delegates using the app will be able to add others to their “favorites” and can contact other participants directly to organize meetings in advance of the Symposium.
WADA encourages participants to make the most of this delegate app in order to maximize communications and networking opportunities in and around the event.
This year's Symposium will also feature a special one-and-a-half-day session for athletes and athlete representatives.
As outlined in the draft agenda, this session will include speakers, workshops and interactive information sessions dedicated to engaging and educating athletes. Important matters in anti-doping such as athlete representation within the anti-doping movement, the Anti-Doping Charter of Athlete Rights, the Anti-Doping Administration and Management System (ADAMS), and much more will be covered and discussed.
WADA wishes to encourage all Anti-Doping Organizations to promote this event to their athletes and athlete representatives.
Please note that once approved, registration for athletes will be free.
Please note that the deadline for booking Symposium-designated hotels at a preferential rate has passed. As the number of hotel rooms in Lausanne is limited, we strongly encourage you to book your accommodation as soon as possible by contacting Lausanne Tourisme.
WADA looks forward to welcoming participants in Lausanne.
World Anti-Doping Agency
An introduction and overview on Anti-Doping.
What is Doping
According to the CPISRA Anti Doping Rules compliant to WADA Code, Doping is defined as:
- Presence of a prohibited Substance or its metabolites or markets , as defined in the WADA Prohibited List in an athlete’s bodily specimen, except when in agreement with a TUE granted for the particular substance.
- Use or attempted use of a Prohibited Substance or Methods.
- Tampering or attempting to temper with any part of Doping Control.
- Violation of applicable requirements regarding Athlete availability for Out-of-Competition Testing for RTP (Registered Testing Pool) athletes.
- Possession or trafficking of Prohibited Substances and Methods.
- Administration or attempted administration of a Prohibited Substance or Method to any athlete , or assisting ,encouraging ,aiding , abetting , covering up or any other type of complicity involving an anti-doping rule.
- Administration or Attempted Administration to any Athlete In-Competition of any Prohibited Substance or Prohibited Method, or Administration or Attempted Administration to any Athlete Out-of-Competition of any Prohibited Substance or any Prohibited Method that is Prohibited Out-of-Competition
–Complicity : Assisting, encouraging, aiding, abetting, conspiring, covering up or any other type of intentional complicity involving an anti-doping rule violation.
–Prohibited Association : Association by an Athlete or other Person subject to the authority of an Anti-Doping Organization in a professional or sport-related capacity with any ineligible Athlete / Support Person because of an Anti-Doping rule Violation or equivalent case.
Why is Doping Prohibited
The sports regulations prohibit Doping. Any violation of this rules, be it voluntary or not, constitutes a failure to respect the principle of equal opportunities and, therefore, a disrespect of the sports ethics.
Moreover, the consumption of substances which improve performances can put health in danger. The athlete who has resort to Doping doesn’t harm only himself but he also negatively affects sports as a whole.
What are the tasks of the CPISRA Anti-Doping Committee
In 2005, CPISRA constituted a Committee for the fight against Doping charged of the execution of controls and the surveillance of the tests. This committee is responsible for education of CP athletes concerning anti doping, for the conception and the respect of the anti doping rules, for the diffusion of the Prohibited list , for the formation and perfection of the controllers and also the provision information and advice. Its activities are defined through the Anti Doping Committee Statue.
What about medicines provided on order?
The athlete who must follow a treatment should draw the attention of his/her physician and/or pharmacist to the list of the relevant Doping substances.
If he/she obtains medicines from abroad, he/she must take care of their composition which is mentioned on the note devoted to the patients. The ideal would be to carry away his/her own medicines.
Each athlete should establish, with the help of his/her physician or pharmacist, a personal list of the medicines that he can consume in case of illness- personal medication notebook, this would prevent him from absorbing prohibited substances involuntarily.
The Therapeutic Use Exemption (TUE)
A TUE may be granted to an Athlete permitting the use of Prohibited Substance or Prohibited Methods as defined by the Prohibited List for the following reasons:
-The Athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of usual health following the treatment of a legitimate medical condition.
-There is no reasonable therapeutic alternative to the Use of the otherwise Prohibited Substance or Prohibited Method.
-The necessity for the Use of the otherwise Prohibited Substance or Prohibited Method cannot be a consequence , wholly or in part , of the prior non –therapeutic Use of substances from the Prohibited List.
How long do the medicines remain detectable in urine?
What is an anti-doping control?
An anti-doping control consists in analyzing, by accredited laboratories, the urine or blood withdrawals of selected athletes in order to track down the prohibited substances. The discovery of such substances results in tacking disciplinary measures against the athlete. Anti-doping control assures the respect of equal opportunities in competition.
Who is submitted to the controls
Who is responsible for anti-doping controls?
Who is in charge of controls?
During the controls, what about disabled athletes?
What does it occur to urine (or blood) withdrawals?
Are the sample of urine (or blood) safe from manipulation?
Are the tests unfailing?
What happens when the result of controls it is negative?
What happens when the result of controls is positive?
The results of Out of competition testing are announced directly by the CPISRA Anti Doping Committee to the athlete.
The athlete can ask in writing for an analysis of the sample B. He has the right to attend this analysis accompanied by an expert and /or a trustworthy person. If the result is negative, the control is declared negative. On the other hand, if the result confirms the one gotten from sample A, the control is declared positive.
The possible sanctions are decided according the CPISRA anti doping rules and applied by the federation of the relevant athlete. Before, the athlete has the right to express himself and to have knowledge of the file. The case must remain confidential until the first instance decision.
It is possible to protest a first instance decision. The protest can be forwarded to an unbiased arbitration court, like WADA and Sport Arbitrary Tribunal in Lausanne.